IMUX
Immunic
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
IMUX fundamentals
Immunic (IMUX) released its earnings on May 15, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.25 (YoY +16.67%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.25
+16.67%
Report date
May 15, 2025
Earnings Call
8:00 AM on May 14, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Immunic (IMUX) key financial stats and ratios, covering profitability, financial health, and leverage.
Immunic (IMUX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Immunic (IMUX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Immunic (IMUX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Immunic (IMUX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Immunic (IMUX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Immunic’s gross profit margin?What factors drove the changes in Immunic’s revenue and profit?What is the market’s earnings forecast for Immunic next quarter?What guidance did Immunic’s management provide for the next earnings period? What is Immunic’s latest dividend and current dividend yield?Did Immunic beat or miss consensus estimates last quarter?How were Immunic’s latest financial results overall?What does Immunic do and what are its main business segments?